Abstract
Using data from the Veterans' Health Administration from 2010 to 2019, we examined the distribution and prevalence of community-acquired phenotypic extended-spectrum β-lactamase (ESBL) E. coli in the United States. ESBL prevalence slowly increased during the study period, and cluster analysis showed clustering in both urban and rural locations.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Cluster Analysis
-
Community-Acquired Infections* / drug therapy
-
Community-Acquired Infections* / epidemiology
-
Escherichia coli
-
Escherichia coli Infections* / drug therapy
-
Escherichia coli Infections* / epidemiology
-
Humans
-
Prevalence
-
beta-Lactamases
Substances
-
beta-Lactamases
-
Anti-Bacterial Agents